Clinicians often believe that cachexia is caused by cancer and anorexia as a toxicity of
chemotherapy or targeted anti-cancer agents. It is now recognized that chemotherapy and …

Loss of skeletal muscle mass and strength is apparent as early as the 4th decade of life and
progresses linearly with increasing age [1, 2]. The term sarcopenia, first introduced by Irwin …

The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …

Background Low skeletal muscle mass (SMM) is associated with postoperative
complications, prolonged hospital stay, and short overall survival (OS) in surgical oncology …

In the context of the management of the elderly patient with cancer, currently, a key topic
may be expressed by sarcopenia. Sarcopenia in its various definitions and ambiguities in …

Objectives Skeletal muscle mass (SMM) is most often assessed in cancer patients on
abdominal computed tomography (CT) imaging at the level of the third lumbar vertebra (L3) …

Background Sarcopenia might be a relevant lead for optimization of the condition of patients
with head and neck cancer (HNC) before chemoradiotherapy (CRT) to prevent long‐term …

Background Researchers increasingly use intraoperative muscle biopsy to investigate
mechanisms of skeletal muscle atrophy in patients with cancer. Muscles have been …

Purpose: Although muscle mass has been associated with survival in patients with various
types of solid tumors, the relationship between muscle mass and survival in patients with …

Skeletal muscle is a highly plastic organ regulating various processes in the body. As such,
loss of skeletal muscle underlies the increased morbidity and mortality risk that is associated …